Case Study: GlaxoSmithKline accelerates drug discovery with Cerebras CS-1

GlaxoSmithKline - Customer Case Study

GlaxoSmithKline, a pharmaceutical company focused on improving human life through innovation, needed an AI solution with larger memory and throughput to take advantage of new neural network models for drug discovery. The company turned to Cerebras to help support increasingly complex encoder models and accelerate its research efforts.

With the Cerebras CS-1 system, GlaxoSmithKline was able to increase model complexity while cutting training time by 80x. Cerebras enabled the team to generate more data faster and improve the pace of drug discovery, delivering a major measurable boost in AI and ML performance.

GlaxoSmithKline

Kim Branson

Senior Vice President Global Head of AI and ML